Contact Us: 1-888-667-3325 /

Subscriber Content Preview | Request a free trialSearch  


As time goes by, shareholders gain power but add little

An alternative to single or dual class structures, popular in France, seems to have no effect on valuation. Few U.S. companies adopt the scheme, which encourages long-term holdings. Continue reading

To win a proxy fight, win the heart of a qualified board nominee

As insurgencies proliferate, investors and targets are fishing in the same limited pool of candidates. Experienced executives are the ideal recruits -- and companies may have an advantage over activists. Continue reading

Obamacare ruling expected to intensify healthcare M&A

Hospitals, REITs and insurers are likely to benefit from the Supreme Court's decision in King v. Burwell. Continue reading

Transition Therapeutics shares plunge 74% on negative clinical trial results

The setback raises the question of whether the company will need to raise capital sooner than previously expected. Continue reading

CVS builds a muscular stake in Medicare

Deal will grow CVS Health's MinuteClinic walk-in clinic franchises and provide Target customers with expanded pharmacy care programs. Continue reading

Negotiating a solution for NECC and fungal meningitis victims

Paul Moore, the Chapter 11 trustee for the Boston pharmacy company, reflects on how the $200 million settlement came to be for those killed and infected during the historic outbreak. Continue reading

Oramed raising $5.36M in registered direct offering, may have to raise more

The Jerusalem-based company is adapting drugs that are usually injected for oral use. Continue reading

Genstar-backed Netsmart Technologies retains adviser for dual track auction and IPO process

A possible sale of the behavioral healthcare IT company could bring in more than $750 million. Continue reading

In its Steris challenge, the FTC sees through Synergy Health's big X-ray sterilization plans

The British target was intending to invade the U.S. market with new technology that would have disrupted its merger partner's business. Those designs now imperil the $1.9 billion deal. Continue reading

Spinout from Ventas-Ardent REIT deal in final auction stages

Private equity firms are interested in the operating company, which could bring in upward of $500 million in a sale. Continue reading

Drugstore operator CVS Health acquires pharmacy benefits manager Omnicare for $12.7B

The purchase provides an entry for CVS into the rapidly growing senior care space. Continue reading

China Inc. goes private -- one mediocre piece at a time

Beijing's restructuring of state-owned enterprises will generate some opportunities for foreign investors, but in a seller's market the government is always looking out mainly for itself. Continue reading

Meet the journalists

William Blair's Dan Shedivy sits down to talk M&A in the healthcare services sector

Middle Market healthcare deals stayed strong in 2014 but were relative ... Video

More Healthcare video

The Deal's Webcast Series

If you have not had the chance to enjoy our Webcast Series, now is the time. Join these free 60-minute discussions and get a handle on the latest strategies and tactics in private equity, cross-border and middle market dealmaking and more.

Industry Events

View information on all upcoming industry events which The Deal representatives are participating in.

The Deal Economy Event

Our senior journalists host the industry's leading forecasting event, where influential members of the deal community discuss the outlook for dealmaking.

The Deal on Twitter

Follow @TheDealNewsroom for the latest news across mergers and acquisitions, auctions, financings, restructurings and more!